Heart failure after left atrial appendage occlusion: Insights from the LAAOS III randomized trial
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, randomizované kontrolované studie
PubMed
39586754
PubMed Central
PMC11860722
DOI
10.1002/ejhf.3536
Knihovny.cz E-zdroje
- Klíčová slova
- Atrial fibrillation, Heart failure, Left atrial appendage, Left atrial appendage occlusion,
- MeSH
- fibrilace síní * chirurgie komplikace MeSH
- incidence MeSH
- kardiochirurgické výkony * metody škodlivé účinky MeSH
- lidé MeSH
- následné studie MeSH
- pooperační komplikace * epidemiologie MeSH
- rizikové faktory MeSH
- senioři MeSH
- síňové ouško * chirurgie MeSH
- srdeční selhání * epidemiologie etiologie MeSH
- tepový objem MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- randomizované kontrolované studie MeSH
AIMS: The left atrial appendage (LAA) produces natriuretic peptides and its removal or occlusion might increase the risk of heart failure (HF). We aimed to investigate the incidence of HF after LAA occlusion or removal (LAAO) in the Left Atrial Appendage Occlusion Study (LAAOS III). METHODS AND RESULTS: Patients (n = 4811) with atrial fibrillation (AF) and a CHA2DS2-VASc score ≥2, who were having cardiac surgery for another indication, were randomized to undergo surgical LAAO or not. We compared the composite outcome of HF-related hospitalizations and HF death between the two groups. HF assessment required clinical and radiographic evidence of HF. Analyses included a landmark analysis before and after 30 days and subgroups. Mean age was 71.2 years, 67.5% were male and 57.0% had prior HF. Over a mean follow-up of 3.8 years, 396 (8.3%) patients met the composite HF outcome: 209 (8.8%) with LAAO (n = 2379) and 187 (7.8%) without LAAO (n = 2391) (hazard ratio [HR] 1.12, 95% confidence interval [CI] 0.92-1.37, p = 0.25). There was no difference between the two groups in the first 30 days (1.6% vs. 1.1%; p = 0.12) and thereafter (7.6% vs. 7.1%; p = 0.57). Subgroups based on age, sex, body mass index, AF type, prior HF, cardiac rhythm or left ventricular ejection fraction showed consistent results. There was no difference in HF outcomes with LAAO between the cut-and-sew (HR 0.93, 95% CI 0.70-1.23, p = 0.62) versus other closure methods (HR 1.05, 95% CI 0.77-1.41, p = 0.77). CONCLUSIONS: Left atrial appendage occlusion or removal at the time of cardiac surgery does not appear to alter the risk of HF-related hospitalization or death. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov NCT01561651.
Auckland City Hospital Auckland New Zealand
Department of Cardiac Surgery University Hospitals Leuven Leuven Belgium
Department of Cardiology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark
Department of Clinical Sciences Malmö Lund University Lund Sweden
Hamilton Health Sciences Hamilton ON Canada
Institute for Clinical and Experimental Medicine Prague Czech Republic
McMaster University Hamilton ON Canada
National Heart and Lung Institute Imperial College London London UK
Population Health Research Institute Hamilton ON Canada
Rhön Klinikum Campus Bad Neustadt Bad Neustadt Germany
University of Melbourne and Royal Melbourne Hospital Melbourne VIC Australia
Zobrazit více v PubMed
Whitlock R, Healey J, Vincent J, Brady K, Teoh K, Royse A, PubMed DOI PMC
Whitlock RP, Belley‐Cote EP, Paparella D, Healey JS, Brady K, Sharma M, PubMed DOI
Healey JS, Oldgren J, Ezekowitz M, Zhu J, Pais P, Wang J, PubMed DOI
Patel NJ, Deshmukh A, Pant S, Singh V, Patel N, Arora S, PubMed DOI
Tabata T, Oki T, Yamada H, Iuchi A, Ito S, Hori T, PubMed DOI
Vargas‐Barron J, Saucedo‐Orozco H, Sanchez‐Mendoza A, Marquez‐Velasco R, Catrip‐Torres JM, Jimenez‐Rojas V, PubMed DOI
Hoit BD, Shao Y, Gabel M. Influence of acutely altered loading conditions on left atrial appendage flow velocities. J Am Coll Cardiol 1994;24:1117–1123. 10.1016/0735-1097(94)90878-8 PubMed DOI
Krisai P, Johnson LSB, Moschovitis G, Benz A, Ramasundarahettige C, McIntyre WF, PubMed DOI PMC
Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, PubMed DOI
Wong JA, Conen D, Van Gelder IC, McIntyre WF, Crijns HJ, Wang J, PubMed DOI
Johnson LSB, Oldgren J, Barrett TW, McNaughton CD, Wong JA, McIntyre WF, PubMed DOI PMC
Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor‐based approach: The Euro Heart Survey on Atrial Fibrillation. Chest 2010;137:263–272. 10.1378/chest.09-1584 PubMed DOI
Morita S, Malik AH, Kuno T, Ando T, Kaul R, Yandrapalli S, PubMed DOI
Piccini JP. Atrial fibrillation and heart failure: Too much talk and not enough action. JACC Clin Electrophysiol 2023;9:581–582. 10.1016/j.jacep.2023.03.003 PubMed DOI PMC
Moreyra AE, Deng Y, Wilson AC, Cosgrove NM, Kostis WJ, Kostis JB; MIDAS 18 Study Group . Incidence and trends of heart failure admissions after coronary artery bypass grafting surgery. Eur J Heart Fail 2013;15:46–53. 10.1093/eurjhf/hfs154 PubMed DOI
Vassileva CM, Ghazanfari N, Spertus J, McNeely C, Markwell S, Hazelrigg S. Heart failure readmission after mitral valve repair and replacement: Five‐year follow‐up in the Medicare population. Ann Thorac Surg 2014;98:1544–1550. 10.1016/j.athoracsur.2014.07.040 PubMed DOI
Lakkireddy D, Turagam M, Afzal MR, Rajasingh J, Atkins D, Dawn B, PubMed DOI
Hoit BD, Shao Y, Tsai LM, Patel R, Gabel M, Walsh RA. Altered left atrial compliance after atrial appendectomy. Influence on left atrial and ventricular filling. Circ Res 1993;72:167–175. 10.1161/01.res.72.1.167 PubMed DOI
Cox JL, Schuessler RB, D'Agostino HJ, Stone CM, Chang BC, Cain ME, PubMed
Healey JS, Crystal E, Lamy A, Teoh K, Semelhago L, Hohnloser SH, PubMed DOI
Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, PubMed DOI PMC
Rillig A, Magnussen C, Ozga AK, Suling A, Brandes A, Breithardt G, PubMed DOI PMC
ClinicalTrials.gov
NCT01561651